Ferumoxytol, esrd use
Products billed under this code include Feraheme, Ferumoxytol.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Feraheme, Ferumoxytol.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Feraheme | Covis Pharma US, Inc | 59338-0775-01 | 510 | $168.81 |
| Ferumoxytol | Sandoz Inc. | 00781-3154-01 | 510 | $168.81 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.331 | −$0.039 | 1 MG | Ferumoxytol, esrd use | v1, posted September 17, 2026 |
| 3Q26 | $0.37 | +$0.141 | 1 MG | Ferumoxytol, esrd use | v1, posted September 15, 2026 |
| 2Q26 | $0.229 | −$0.131 | 1 MG | Ferumoxytol, esrd use | v1, posted September 15, 2026 |
| 1Q26 | $0.36 | +$0.036 | 1 MG | Ferumoxytol, esrd use | v1, posted September 15, 2026 |
| 4Q25 | $0.324 | +$0.016 | 1 MG | Ferumoxytol, esrd use | v1, posted September 8, 2026 |
| 3Q25 | $0.308 | −$0.02 | 1 MG | Ferumoxytol, esrd use | v1, posted March 10, 2026 |
| 2Q25 | $0.328 | −$0.049 | 1 MG | Ferumoxytol, esrd use | v1, posted March 10, 2026 |
| 1Q25 | $0.377 | +$0.039 | 1 MG | Ferumoxytol, esrd use | v1, posted December 19, 2025 |
| 4Q24 | $0.338 | +$0.007 | 1 MG | Ferumoxytol, esrd use | v1, posted June 11, 2025 |
| 3Q24 | $0.331 | −$0.063 | 1 MG | Ferumoxytol, esrd use | v1, posted June 11, 2025 |
| 2Q24 | $0.394 | +$0.037 | 1 MG | Ferumoxytol, esrd use | v1, posted March 11, 2025 |
| 1Q24 | $0.357 | −$0.146 | 1 MG | Ferumoxytol, esrd use | v1, posted December 19, 2024 |
| 4Q23 | $0.503 | $0.00 | 1 MG | Ferumoxytol, esrd use | v1, posted October 10, 2024 |
| 3Q23 | $0.503 | +$0.025 | 1 MG | Ferumoxytol, esrd use | v1, posted June 5, 2024 |
| 2Q23 | $0.478 | −$0.078 | 1 MG | Ferumoxytol, esrd use | v1, posted February 23, 2024 |
| 1Q23 | $0.556 | +$0.023 | 1 MG | Ferumoxytol, esrd use | v1, posted December 6, 2023 |
| 4Q22 | $0.533 | −$0.169 | 1 MG | Ferumoxytol, esrd use | v1, posted June 22, 2023 |
| 3Q22 | $0.702 | −$0.232 | 1 MG | Ferumoxytol, esrd use | v1, posted June 9, 2023 |
| 2Q22 | $0.934 | −$0.063 | 1 MG | Ferumoxytol, esrd use | v1, posted December 14, 2022 |
| 1Q22 | $0.997 | $0.00 | 1 MG | Ferumoxytol, esrd use | v1, posted June 8, 2022 |
| 4Q21 | $0.997 | +$0.044 | 1 MG | Ferumoxytol, esrd use | v1, posted June 2, 2022 |
| 3Q21 | $0.953 | −$0.015 | 1 MG | Ferumoxytol, esrd use | v1, posted June 2, 2022 |
| 2Q21 | $0.968 | +$0.036 | 1 MG | Ferumoxytol, esrd use | v1, posted March 1, 2022 |
| 1Q21 | $0.932 | – | 1 MG | Ferumoxytol, esrd use | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.